Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05893524 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Uppsala-Dalarna Dementia and Gait Project

Study acronym: UDDGait™
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Site contacts updated at 1 of 2 sitesv2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1,978 trials monitored
See 106 trials at risk
UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions. A new concept is investigated for this purpose: a "dual-task-test", which implies the combination of a well-established mobility test (Timed Up-and-Go, TUG) with a simultaneous verbal task (i.e. TUG dual-task, TUGdt). This type of test has been judged as a potential aid for early identification of dementia disease. More research is needed to further examine the test's validity, reliability and predictive capacity. The overall aim is to investigate if TUGdt is useful as an aid for prediction of dementia disease. To ensure the results, the aim is also to evaluate the test's measurement properties and to generate normative reference values of healthy control persons.
Trial Details
NCT Number NCT05893524
Lead Sponsor Dalarna University
Collaborators: Uppsala University, The Swedish Research Council
Conditions
(from sponsor)
Dementia, Dementia, Mixed, Dementia Senile, Dementia of Alzheimer Type, Mild Cognitive Impairment, Subjective Cognitive Impairment
Related terms Alzheimer Disease, Cognitive Dysfunction, Dementia, Mixed Dementias
Enrollment 550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov